www.delta4.ai
🌐 Learn more about our commitment!
delta4.ai/gender-equal...
#Delta4 #GenderEquality
🌐 Learn more about our commitment!
delta4.ai/gender-equal...
#Delta4 #GenderEquality
Delta4 combines AI, biology, and drug development expertise to optimize your pipeline from start to finish.
Learn more here!
delta4.ai/development-...
#Delta4 #Pipeline
Delta4 combines AI, biology, and drug development expertise to optimize your pipeline from start to finish.
Learn more here!
delta4.ai/development-...
#Delta4 #Pipeline
Delta4 will be at BIO-Europe 2025 in Vienna, Nov 3–5.
Meet our CSO, Dr. Klaus Kratochwill, and discover how our Hyper-C platform can help unlock new therapeutic opportunities.
📩 DM us to schedule a meeting at the conference!
Delta4 will be at BIO-Europe 2025 in Vienna, Nov 3–5.
Meet our CSO, Dr. Klaus Kratochwill, and discover how our Hyper-C platform can help unlock new therapeutic opportunities.
📩 DM us to schedule a meeting at the conference!
🔍 At the molecular level, amyloidosis represents a convergence of protein misfolding, proteostasis imbalance, and chronic inflammation. Our Hyper-C platform is modeling diseases as dynamic molecular networks to find new solutions for such complex diseases.
🔍 At the molecular level, amyloidosis represents a convergence of protein misfolding, proteostasis imbalance, and chronic inflammation. Our Hyper-C platform is modeling diseases as dynamic molecular networks to find new solutions for such complex diseases.
#Delta4 #PICKEDProject
#Delta4 #PICKEDProject
At Delta4, we harness the power of AI-supported drug repurposing to accelerate breakthroughs and bring new possibilities to those who need them most.
Together, we can change the future of rare disease care.
#Delta4
At Delta4, we harness the power of AI-supported drug repurposing to accelerate breakthroughs and bring new possibilities to those who need them most.
Together, we can change the future of rare disease care.
#Delta4
#AIinBiotech
#AIinBiotech
Looking to expand indications, identify new targets, or discover innovative drug combinations? Meet our CSO and explore how we can unlock new therapeutic opportunities with the help of our platform, Hyper-C.
📩 DM us to schedule a meeting at the conference!
Looking to expand indications, identify new targets, or discover innovative drug combinations? Meet our CSO and explore how we can unlock new therapeutic opportunities with the help of our platform, Hyper-C.
📩 DM us to schedule a meeting at the conference!
Learn more about how we’re changing the game in drug repurposing: delta4.ai/development-...
Learn more about how we’re changing the game in drug repurposing: delta4.ai/development-...
Today, September 30th, join us and Concept Life Sciences for a webinar on:
"Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration".
👉 Register now and join the discussion: lnkd.in/ePUadeBE
Today, September 30th, join us and Concept Life Sciences for a webinar on:
"Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration".
👉 Register now and join the discussion: lnkd.in/ePUadeBE
Repositioned drugs like SGLT2i, GLP1RAs, MRAs & ERAs show strong cardiorenal benefits. At Delta4, we advance this field with computational & biological insights. Read our Proteomics viewpoint:
analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/...
Repositioned drugs like SGLT2i, GLP1RAs, MRAs & ERAs show strong cardiorenal benefits. At Delta4, we advance this field with computational & biological insights. Read our Proteomics viewpoint:
analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/...
Springer Nature launches a collection on molecular & imaging-guided precision intervention in #prostate #cancer, edited by Harald Mischak.
Submit work on biomarkers, AI-driven imaging, or targeted therapies. 🔗 link.springer.com/.
#CallForPapers
Springer Nature launches a collection on molecular & imaging-guided precision intervention in #prostate #cancer, edited by Harald Mischak.
Submit work on biomarkers, AI-driven imaging, or targeted therapies. 🔗 link.springer.com/.
#CallForPapers
From drug discovery to personalised kidney care, support + science are driving real impact in the PICKED project.
🎥 Watch here: www.youtube.com/watch?v=Tswy...
#PICKEDproject #CKD #MSCA #HorizonEU #DrugDiscovery
From drug discovery to personalised kidney care, support + science are driving real impact in the PICKED project.
🎥 Watch here: www.youtube.com/watch?v=Tswy...
#PICKEDproject #CKD #MSCA #HorizonEU #DrugDiscovery
This day reminds us of the complexity of Alzheimer’s disease and the need to better understand the brain’s immune and support cells. Astrocytes are now seen as central players—join our Sept 30 webinar with Concept Life Sciences to learn more.
This day reminds us of the complexity of Alzheimer’s disease and the need to better understand the brain’s immune and support cells. Astrocytes are now seen as central players—join our Sept 30 webinar with Concept Life Sciences to learn more.
Join us on Sept 30th to see how we combine neuroscience expertise with Delta4’s Hyper-C platform to identify novel targets in neurodegeneration!
📅 Register here: tinyurl.com/CNSwebinar25
Join us on Sept 30th to see how we combine neuroscience expertise with Delta4’s Hyper-C platform to identify novel targets in neurodegeneration!
📅 Register here: tinyurl.com/CNSwebinar25
We recognize that the fight against sepsis transcends acute care and is about leveraging innovation in computational research to deliver therapies faster, more safely, and tailored to patient needs.
We recognize that the fight against sepsis transcends acute care and is about leveraging innovation in computational research to deliver therapies faster, more safely, and tailored to patient needs.
🎓 Meet Louiza, who is investigating synthetic lethality - targeting gene interactions that selectively kill cancer cells.
Stay tuned as we share further insights from this exciting collaboration!
🎓 Meet Louiza, who is investigating synthetic lethality - targeting gene interactions that selectively kill cancer cells.
Stay tuned as we share further insights from this exciting collaboration!
It was the perfect chance to step away from our projects, enjoy good food, and spend some quality time together outside the office. Team spirit is well paired with sunshine! 🥂
It was the perfect chance to step away from our projects, enjoy good food, and spend some quality time together outside the office. Team spirit is well paired with sunshine! 🥂
In our joint work with Concept Life Sciences, we will be hosting a webinar on September 30th where we’ll explore how computation and biology can unlock new targets in neuroinflammation.
👉 insidescientific.com/webinar/unit...
In our joint work with Concept Life Sciences, we will be hosting a webinar on September 30th where we’ll explore how computation and biology can unlock new targets in neuroinflammation.
👉 insidescientific.com/webinar/unit...
🧪 At Delta4, our in-silico drug discovery platform is being applied to uncover existing compounds applicable for ADPKD.
Let’s amplify the voices of those affected and support continued research into this challenging condition!
#ADPKD
🧪 At Delta4, our in-silico drug discovery platform is being applied to uncover existing compounds applicable for ADPKD.
Let’s amplify the voices of those affected and support continued research into this challenging condition!
#ADPKD
💡 Using AI-supported molecular modeling, it connects compounds to diseases with speed and precision, turning big data into big results. 🚀
Learn more about it: 👉 delta4.ai/hyper-c/
#Delta4 #HyperC
💡 Using AI-supported molecular modeling, it connects compounds to diseases with speed and precision, turning big data into big results. 🚀
Learn more about it: 👉 delta4.ai/hyper-c/
#Delta4 #HyperC